Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
europe blog main
europe top stories
fda
life sciences
national blog main
national top stories
abbvie
alkermes
allergan
arena pharmaceuticals
boulder/denver blog main
boulder/denver top stories
buprenorphine
cancer
cardiovascular disease
cariprazine
colorectal cancer
detroit blog main
detroit top stories
eisai
eli lilly
europe
felipe jain
indiana blog main
indiana top stories
jess fiedorowicz
jessica jeffrey
karim calis
lorcaserin
lumateperone
lung cancer
m health fairview
marc goodman
massachusetts general hospital
national
national institutes of health (nih)
What
drug
fda
2
×
medicine
2
×
weight
2
×
alkermes
antipsychotic
benefits
cancer
caveats
commonly
designed
effect
eisai
favor
flags
gain
higher
incidence
lorcaserin
loss
market
marketing
offer
panel
patients
post
prescribed
psyche
pulls
risks
study
took
treatment
vote
weighs
withdrawing
won
Language
unset
Current search:
weight
×
medicine
×
fda
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
